Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2017

van Ginkel Joost H, Huibers Manon M H, Noorlag Rob, de Bree Remco, van Es Robert J J, Willems Stefan M

Abstract excerpt

The prognosis of head and neck squamous cell carcinoma (HNSCC) is largely based on disease stage. Despite improvements in treatment, recurrence rates are still considered high. Currently, disease progression or regression after curative treatment is monitored by clinical evaluation combined with flexible endoscopy and/or imaging. However, specificity of imaging is low due to the posttreatment effects. Detection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Liquid Biopsy

Share to Prognosis

Share to Sensitivity and Specificity

Share to Tumor Suppressor Protein p53

Share to Workflow

Source

Identifiers

PMID: 27974721
DOI: 10.1159/000452861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?PMID 27974721Read ↗

Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?Semantic proximity Read ↗

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinomaSemantic proximity Read ↗

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinomaSemantic proximity Read ↗

Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.Semantic proximity Read ↗

Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectivesSemantic proximity Read ↗

Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma.Semantic proximity Read ↗

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.Semantic proximity Read ↗

Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisSemantic proximity Read ↗

Liquid biopsies for hepatocellular carcinoma.Semantic proximity Read ↗

Emerging strategies for the early detection and prevention of head and neck squamous cell cancerSemantic proximity Read ↗

Molecular diagnosis of nasopharyngeal carcinoma: Past and future.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.